Float Short %

5.49

Margin Of Safety %

Put/Call OI Ratio

0.21

EPS Next Q Diff

0.17

EPS Last/This Y

0.5

EPS This/Next Y

0.2

Price

13.34

Target Price

19.33

Analyst Recom

Performance Q

27.29

Relative Volume

0.88

Beta

0.47

Ticker: ANGO

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-17	ANGO	11.9	0.22	0.00	3009
2025-11-18	ANGO	11.87	0.22	0.87	3019
2025-11-19	ANGO	11.9	0.22	8.57	3056
2025-11-20	ANGO	11.43	0.20	0.00	2997
2025-11-21	ANGO	11.94	0.20	0.47	2991
2025-11-24	ANGO	12.3	0.22	0.00	2061
2025-11-25	ANGO	12.4	0.21	0.00	2133
2025-11-26	ANGO	12.29	0.21	0.00	2143
2025-12-01	ANGO	12.96	0.21	0.21	2172
2025-12-02	ANGO	13.38	0.21	0.02	2180
2025-12-03	ANGO	13.48	0.21	0.56	2187
2025-12-04	ANGO	13.63	0.21	0.07	2186
2025-12-05	ANGO	13.47	0.21	0.00	2212
2025-12-08	ANGO	13.25	0.21	0.00	2216
2025-12-09	ANGO	13.14	0.21	0.00	2216
2025-12-10	ANGO	13.34	0.21	0.00	2216
2025-12-11	ANGO	13.44	0.21	0.24	2216
2025-12-12	ANGO	13.14	0.21	0.00	2231
2025-12-15	ANGO	13.36	0.21	0.21	2231
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-17	ANGO	11.90	-143.7	-	-0.32
2025-11-18	ANGO	11.88	-143.7	-	-0.32
2025-11-19	ANGO	11.90	-143.7	-	-0.32
2025-11-20	ANGO	11.42	-143.7	-	-0.32
2025-11-21	ANGO	11.94	-143.7	-	-0.32
2025-11-24	ANGO	12.29	-143.7	-	-0.32
2025-11-25	ANGO	12.40	-143.7	-	-0.32
2025-11-26	ANGO	12.30	-143.7	-	-0.32
2025-12-01	ANGO	12.98	-143.7	-	-0.32
2025-12-02	ANGO	13.37	-143.7	-	-0.32
2025-12-03	ANGO	13.49	-143.7	-	-0.32
2025-12-04	ANGO	13.62	-143.7	-	-0.32
2025-12-05	ANGO	13.47	-150.0	-	-0.33
2025-12-08	ANGO	13.26	-150.0	-	-0.33
2025-12-09	ANGO	13.16	-150.0	-	-0.33
2025-12-10	ANGO	13.16	-150.0	-	-0.33
2025-12-11	ANGO	13.44	-150.0	-	-0.33
2025-12-12	ANGO	13.14	-150.0	-	-0.33
2025-12-15	ANGO	13.34	-150.0	-	-0.33
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-17	ANGO	0.90	-2.93	6.43
2025-11-18	ANGO	0.90	-2.93	6.43
2025-11-19	ANGO	0.90	-2.93	6.43
2025-11-20	ANGO	0.90	-2.93	6.43
2025-11-21	ANGO	0.90	-2.93	6.43
2025-11-24	ANGO	0.90	3.42	6.43
2025-11-25	ANGO	0.90	3.42	6.43
2025-11-26	ANGO	0.90	3.42	5.60
2025-12-01	ANGO	0.90	3.46	5.60
2025-12-02	ANGO	0.90	3.46	5.60
2025-12-03	ANGO	0.90	3.46	5.60
2025-12-04	ANGO	0.90	3.46	5.60
2025-12-05	ANGO	0.90	3.46	5.60
2025-12-08	ANGO	0.90	3.77	5.60
2025-12-09	ANGO	0.90	3.77	5.60
2025-12-10	ANGO	0.90	3.77	5.49
2025-12-11	ANGO	0.90	3.77	5.49
2025-12-12	ANGO	0.90	3.77	5.49
2025-12-15	ANGO	0.90	3.77	5.49
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="ANGO" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

-0.26

Avg. EPS Est. Current Quarter

-0.1

Avg. EPS Est. Next Quarter

-0.09

Insider Transactions

0.9

Institutional Transactions

3.77

Beta

0.47

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

58.3

Max Drawdown 5-Year %

-83

Target Price

19.33

P/E

Forward P/E

PEG

P/S

1.83

P/B

3.09

P/Free Cash Flow

EPS

-0.78

Average EPS Est. Cur. Y

-0.33

EPS Next Y. (Est.)

-0.13

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-10.67

Relative Volume

0.88

Return on Equity vs Sector %

-44.9

Return on Equity vs Industry %

-27.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”ANGO” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANGO” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANGO” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANGO” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANGO” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANGO” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANGO” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

AngioDynamics, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 675

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

stock quote shares ANGO – Angiodynamic Inc Stock Price stock today

news today ANGO – Angiodynamic Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ANGO – Angiodynamic Inc yahoo finance google finance

stock history ANGO – Angiodynamic Inc invest stock market

stock prices ANGO premarket after hours

ticker ANGO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ANGO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y